(Q44915727)

7 December 2017

Inhibition of VEGFR2 prevents DMBA-induced mammary tumor formation (English)

1 reference

7 December 2017

Sue C Heffelfinger

1

1 reference

7 December 2017

Mei Yan

2

1 reference

7 December 2017

Robin B Gear

3

1 reference

7 December 2017

Joanne Schneider

4

1 reference

7 December 2017

Kathy LaDow

5

1 reference

7 December 2017

David Warshawsky

6

1 reference

7 December 2017

1 August 2004

1 reference

7 December 2017

Laboratory Investigation

1 reference

7 December 2017

84

1 reference

7 December 2017

989-998

1 reference

7 December 2017

8

1 reference

https://scigraph.springernature.com/pub.10.1038/labinvest.3700128

7 December 2017

0 references

cites work

What Is the Evidence That Tumors Are Angiogenesis Dependent?

1 reference

https://api.crossref.org/works/10.1038%2FLABINVEST.3700128

Tumor angiogenesis and metastasis--correlation in invasive breast carcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLABINVEST.3700128

Distinct angiogenic patterns are associated with high-grade in situ ductal carcinomas of the breast.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLABINVEST.3700128

DMBA-induced mammary pathologies are angiogenic in vivo and in vitro

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLABINVEST.3700128

Histopathologic types of benign breast lesions and the risk of breast cancer: case-control study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLABINVEST.3700128

Tamoxifen ("Nolvadex"): a review.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLABINVEST.3700128

TNP-470 inhibits 7,12-dimethylbenz[a]anthracene-induced mammary tumor formation when administered before the formation of carcinoma in situ but is not additive with tamoxifen

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLABINVEST.3700128

L-type voltage-dependent calcium channel alpha-1C subunit mRNA is present in ejaculated human spermatozoa

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLABINVEST.3700128

Expression of angiogenic factors is upregulated in DMBA-induced rat mammary pathologies

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLABINVEST.3700128

Current therapy for multiple myeloma

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLABINVEST.3700128

Vascular endothelial cell growth factor (VEGF), an emerging target for cancer chemotherapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLABINVEST.3700128

Neuropilin-1 is expressed by endothelial and tumor cells as an isoform-specific receptor for vascular endothelial growth factor

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLABINVEST.3700128

Neuropilin-1 participates in wound angiogenesis

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLABINVEST.3700128

Heritable formation of pancreatic beta-cell tumours in transgenic mice expressing recombinant insulin/simian virus 40 oncogenes

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLABINVEST.3700128

Effects of angiogenesis inhibitors on multistage carcinogenesis in mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLABINVEST.3700128

Angiogenesis as a biomarker and target in cancer chemoprevention

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLABINVEST.3700128

Thrombospondin-1 acts as a fence to inhibit angiogenesis that occurs during cervical carcinogenesis

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLABINVEST.3700128

Role of prostaglandin E2-dependent angiogenic switch in cyclooxygenase 2-induced breast cancer progression

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLABINVEST.3700128

Expression of VEGF and its receptors by myeloma cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLABINVEST.3700128

Microvessel density and distribution in ductal carcinoma in situ of the breast

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLABINVEST.3700128

7 January 2021

Morphometric evaluation of microvessels surrounding hyperplastic and neoplastic mammary lesions

1 reference

https://api.crossref.org/works/10.1038%2FLABINVEST.3700128

7 January 2021

Renal ischemia-reperfusion increases endothelial VEGFR-2 without increasing VEGF or VEGFR-1 expression

1 reference

https://api.crossref.org/works/10.1038%2FLABINVEST.3700128

7 January 2021

Steady-state mRNA expression for growth factors in DMBA-induced rat mammary tumors

1 reference

https://api.crossref.org/works/10.1038%2FLABINVEST.3700128

7 January 2021

Analysis of PDZ domain-ligand interactions using carboxyl-terminal phage display

1 reference

https://api.crossref.org/works/10.1038%2FLABINVEST.3700128

7 January 2021

The ‘angiogenic switch’ in the progression from Barrett's metaplasia to esophageal adenocarcinoma

1 reference

https://api.crossref.org/works/10.1038%2FLABINVEST.3700128

7 January 2021

10.1038/LABINVEST.3700128

Identifiers

DOI

1 reference

7 December 2017

1 reference